NAD+ targets cellular energy production and DNA repair at the mitochondrial level
This finding has clinical relevance for: Diabetic ulcers Pressure sores Surgical wound dehiscence Radiation-induced skin damage Chemical and thermal burns In practice, BPC-157 can be administered topically (in compounded creams), locally (via injection into wound margins), or systemically (subcutaneous injection) depending on the wound type and location
Thus, we have successfully designed a peptide optimized for cellular applications
Efficacy in Humans : Gastrointestinal Benefits : For individuals with gut issues, oral BPC-157 may provide general anti-inflammatory benefits
ClinicalTrials.gov lists ongoing studies
This mechanism distinguishes 5-Amino-1MQ from NAD+ precursors (NMN, NR), which provide substrate for NAD+ synthesis